Search research articles
Contact Us
Filters
Showing results (261-270 of 548) with videos related to
Page
of 55
Sort By:
Cancer Medicine
|
July 6, 2024
Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors
Agostina Stradella, Melissa Johnson, Sanjay Goel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 2, 2019
Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLC
Todd M Bauer, Benjamin Besse, Alex Martinez-Marti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 2021
Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx
Caroline Hoffmann, Valentin Calugaru, Edith Borcoman, et al.
Molecular Cancer Therapeutics
|
April 3, 2016
Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies
Daniel Azuara, Cristina Santos, Adriana Lopez-Doriga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2017
Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors
Malaka Ameratunga, Maxime Chénard-Poirier, Irene Moreno Candilejo, et al.
Human Mutation
|
November 15, 2013
ICO amplicon NGS data analysis: a Web tool for variant detection in common high-risk hereditary cancer genes analyzed by amplicon GS Junior next-generation sequencing
Adriana Lopez-Doriga, Lídia Feliubadaló, Mireia Menéndez, et al.
Neuro-Oncology
|
December 1, 2022
Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, "window-of-opportunity" study
Victor Moreno, Juan Manuel Sepúlveda, David A Reardon, et al.
Investigational New Drugs
|
August 9, 2023
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study
Rebecca Kristeleit, Alexandra Leary, Jean Pierre Delord, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2022
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy
Jennifer R Diamond, Valentina Boni, Emerson Lim, et al.
Journal for Immunotherapy of Cancer
|
August 11, 2025
First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors
Michele Maio, Victor Moreno, Juan Martin-Liberal, et al.
Page
of 55
Search research articles
Search
Showing results (261-270 of 548) with videos related to
Sort By:
Page
of 55
Cancer Medicine
|
July 6, 2024
Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors
Agostina Stradella, Melissa Johnson, Sanjay Goel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 2, 2019
Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLC
Todd M Bauer, Benjamin Besse, Alex Martinez-Marti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 2021
Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx
Caroline Hoffmann, Valentin Calugaru, Edith Borcoman, et al.
Molecular Cancer Therapeutics
|
April 3, 2016
Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies
Daniel Azuara, Cristina Santos, Adriana Lopez-Doriga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2017
Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors
Malaka Ameratunga, Maxime Chénard-Poirier, Irene Moreno Candilejo, et al.
Human Mutation
|
November 15, 2013
ICO amplicon NGS data analysis: a Web tool for variant detection in common high-risk hereditary cancer genes analyzed by amplicon GS Junior next-generation sequencing
Adriana Lopez-Doriga, Lídia Feliubadaló, Mireia Menéndez, et al.
Neuro-Oncology
|
December 1, 2022
Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, "window-of-opportunity" study
Victor Moreno, Juan Manuel Sepúlveda, David A Reardon, et al.
Investigational New Drugs
|
August 9, 2023
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study
Rebecca Kristeleit, Alexandra Leary, Jean Pierre Delord, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2022
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy
Jennifer R Diamond, Valentina Boni, Emerson Lim, et al.
Journal for Immunotherapy of Cancer
|
August 11, 2025
First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors
Michele Maio, Victor Moreno, Juan Martin-Liberal, et al.
Page
of 55